pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
NNI-362
Alzheimer's Disease
NeuroNascent Inc
0
catalysts
Phase 1
NO-13065
Obesity
Otsuka Pharmaceutical Co Ltd
0
catalysts
Preclinical
NOD-2
Unspecified Cancer
Nodus Oncology Ltd
0
catalysts
Preclinical
NOD-800
Geographic Atrophy
← prev
page 113 of 231
next →
131
Pain
89
Neurology
1
Nanoscope Therapeutics Inc
0
catalysts
NORELGESTROMIN AND ETHINYL ESTRADIOL
NORELGESTROMIN AND ETHINYL ESTRADIOL (NORELGESTROMIN AND ETHINYL ESTRADIOL)
ZYDUS PHARMS
0
catalysts
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)
GLENMARK PHARMS LTD
0
catalysts
NORGESIC
NORGESIC (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE)
GALT PHARMS
0
catalysts
NORMOSOL-R
NORMOSOL-R (SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE)
OTSUKA ICU MEDCL
0
catalysts
Preclinical
NOS-01
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Nospharma
0
catalysts
Phase 2
NOUS-209
Gastric Cancer
Nouscom AG
0
catalysts
Phase 1
NOVA-1010
Schizophrenia
Novastage Pharmaceuticals (Shenzhen) Ltd
0
catalysts
NOVOLIN R
NOVOLIN R (HUMAN INSULIN)
Novo Nordisk Inc
0
catalysts
Preclinical
NOVS-100
Obesity
Celloram Inc
0
catalysts
pre_registration
NP-001
Amyotrophic Lateral Sclerosis
Neuvivo Inc
0
catalysts
Phase 3
NP-028
Coronavirus Disease 2019 (COVID-19)
$EBS
Emergent BioSolutions Inc.
0
catalysts
Phase 1
NP-10679
Subarachnoid Hemorrhage
NeurOp Inc
0
catalysts
Phase 2
NP-213
Novexatin
Onychomycosis (Tinea Unguium)
Novabiotics Ltd
0
catalysts
Phase 1
NP-3
Nephropathic Cystinosis
Nacuity Pharmaceuticals Inc
0
catalysts
Preclinical
NP-4
Cystinosis
Nacuity Pharmaceuticals Inc
0
catalysts
Preclinical
NP-6A
Cardiomyopathy
Novopyxis Inc
0
catalysts
Preclinical
NP-855
Neuroblastoma
NanoPharmaceuticals LLC
0
catalysts
Preclinical
NPC-31
Neurodegenerative Diseases
Nobelpharma Co Ltd
0
catalysts
Phase 3
NPG-2044
Ovarian Cancer
Novita Pharmaceuticals Inc
0
catalysts
Phase 1
NPX-887
Adenocarcinoma Of The Gastroesophageal Junction
NextPoint Therapeutics Inc
0
catalysts
Preclinical
NRDN-101
Type 1 Diabetes (Juvenile Diabetes)
Neurodon LLC
0
catalysts
Phase 1
NRL-1049
Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hema…
Neurelis Inc
0
catalysts
Phase 1
NRS-033
Opium (Opioid) Addiction
Nirsum Laboratories Inc
0
catalysts
Phase 2
NRT-023
Post Partum Depression (Maternal Depression / Postnatal Depression)
Nanjing Noratech Pharmaceutical Inc
0
catalysts
Phase 3
NRTX-1001
Epilepsy
Neurona Therapeutics Inc
0
catalysts
Preclinical
NS-002
Hyperammonemia
Nano Scrips
0
catalysts
